The Week in Review: China Deals and Healthcare Stimulus
November 29, 2008 at 12:07 PM EST
China promised to spend 4.8 billion RMB ($702 million) on rural healthcare infrastructure; Tigermed Consulting (泰格医药科技有限公司) announced new partnerships with CROs in Russia and Korea; Lilly expanded its drug discovery and development partnership with Hutchison China Meditech; Smiths Group acquired Zhejiang Zheda Medical Instrument; AnaSpec signed a distribution agreement with Shanghai Universal Biotech Company; and Tongjitang Chinese Medicines Company (同济堂药业) released a lower Q3 earnings report. More details... Stock Symbols: (NYSE: LLY) (LSE: HCM) (LSE: SMIN) (NYSE: TCM)
